ABVC Abvc Biopharma Inc
Price (delayed)
$0.855
Market cap
$13.49M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$0.42
Enterprise value
$15.06M
Highlights
The gross profit has grown by 38% since the previous quarter
The gross margin is up by 38% since the previous quarter
Abvc Biopharma's EPS has shrunk by 83% QoQ but it has surged by 77% YoY
The quick ratio is up by 28% year-on-year but it has declined by 3% since the previous quarter
ABVC's equity has dropped by 85% since the previous quarter and by 21% year-on-year
Key stats
What are the main financial stats of ABVC
Market
Valuations
Earnings
Shares outstanding
15.78M
Market cap
$13.49M
Enterprise value
$15.06M
Price to earnings (P/E)
N/A
Price to book (P/B)
9.05
Price to sales (P/S)
19.59
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
29.55
Revenue
$509,589
Gross profit
$508,826
Operating income
-$4.71M
Net income
-$4.9M
EBIT
-$4.19M
EBITDA
-$3.99M
Free cash flow
-$1.81M
Per share
Balance sheet
Liquidity
EPS
-$0.42
EPS diluted
-$0.42
Free cash flow per share
-$0.15
Book value per share
$0.09
Revenue per share
$0.04
TBVPS
$0.65
Total assets
$7.54M
Total liabilities
$6.82M
Debt
$2.43M
Equity
$1.23M
Working capital
-$4.38M
Debt to equity
1.98
Current ratio
0.33
Quick ratio
0.32
Net debt/EBITDA
-0.39
Margins
Efficiency
Dividend
EBITDA margin
-782.3%
Gross margin
99.9%
Net margin
-962.1%
Operating margin
-923.3%
Return on assets
-38.4%
Return on equity
-76.4%
Return on invested capital
-53%
Return on capital employed
-426.2%
Return on sales
-821.7%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
ABVC stock price
How has the Abvc Biopharma stock price performed over time
Intraday
-11.86%
1 week
-18.57%
1 month
31.42%
1 year
-16.18%
YTD
44.92%
QTD
-19.34%
Financial performance
How have Abvc Biopharma's revenue and profit performed over time
Revenue
$509,589
Gross profit
$508,826
Operating income
-$4.71M
Net income
-$4.9M
Gross margin
99.9%
Net margin
-962.1%
The net margin has soared by 81% YoY and by 11% from the previous quarter
The operating margin has soared by 79% year-on-year and by 3.6% since the previous quarter
The gross profit has grown by 38% since the previous quarter
The gross margin is up by 38% since the previous quarter
Growth
What is Abvc Biopharma's growth rate over time
Valuation
What is Abvc Biopharma stock price valuation
P/E
N/A
P/B
9.05
P/S
19.59
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
29.55
Abvc Biopharma's EPS has shrunk by 83% QoQ but it has surged by 77% YoY
ABVC's equity has dropped by 85% since the previous quarter and by 21% year-on-year
The P/S is 87% lower than the last 4 quarters average of 149.3
Efficiency
How efficient is Abvc Biopharma business performance
Abvc Biopharma's return on sales has surged by 80% YoY and by 4% QoQ
The company's return on equity has surged by 71% YoY and by 10% QoQ
The ROA has grown by 45% year-on-year and by 11% since the previous quarter
ABVC's ROIC is up by 27% YoY
Dividends
What is ABVC's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for ABVC.
Financial health
How did Abvc Biopharma financials performed over time
ABVC's total assets is 11% greater than its total liabilities
ABVC's total assets is down by 48% since the previous quarter and by 3.1% year-on-year
The quick ratio is up by 28% year-on-year but it has declined by 3% since the previous quarter
The debt is 98% more than the equity
ABVC's equity has dropped by 85% since the previous quarter and by 21% year-on-year
The debt to equity has increased by 19% year-on-year
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.